Adenocarcinoma of ectopic pancreas

Ectopic pancreas adenocarcinoma is a very rare form of aberrant pancreas. It is part of differential diagnosis of submucosal tumors. The final diagnosis is based on the histological analysis. Surgery is the standard treatment for those tumours. This case illustrates this pathology.

Aberrant Pancreas: Diagnostics and Therapeutic Tactics. Clinical Observation

Aberrant pancreas is a result of impaired embryogenesis. The clinical presentation varies and mimics different diseases. The diagnostics complexity makes specialists conduct the patients’ work-up more thoroughly. Chronic recurrent pancreatitis is one of pancreatic cancer risk factors. Tobacco and alcohol consumption significantly increases the risk of developing aberrant pancreas. The article presents a clinical case of a 37-year-old man with a 10-year history of chronic pancreatitis mainly highlighting the diagnostics of aberrant pancreas. The disease manifested with an episode of acute pancreatitis and pancreonecrosis treated in a hospital. Pancreatic pseudocysts were diagnosed four years later. However, only six years after, aberrant pancreas in stomach and cystic dystrophy of duodenal wall were diagnosed. Accurate diagnosis allowed tailored treatment and avoiding surgery.

Duodenal dystrophy – an interdisciplinary problem

Duodenal dystrophy is a chronic inflammation of the tissues of the pancreas, ectopic into the wall of the duodenum. Duodenal dystrophy is a variant of the aberrant pancreas. Its most frequent complications are acute or chronic pancreatitis, and a violation of duodenal passability, which, along with severe pain are indications for surgical treatment. Pancreaticoduodenal resection is recognized as an operation of choice. The data of patients with duodenal dystrophy observed in MCSC are presented. A clinical case is demonstrating the effective elimination of pain after the laparoscopic pancreaticoduodenal resection, albeit being accompanied by the development of pancreatic insufficiency which requires constant enzyme replacement therapy.